Creatio in 2024
2024 was a key year for CREATIO, the leading academic center for the Production and Validation of Advanced Therapies, affiliated with the University of Barcelona. As a technology developer, CREATIO offers services across the entire value chain—from basic research and preclinical development to clinical production under GMP conditions.
With a comprehensive and results-oriented vision, CREATIO actively promotes innovation and the translation of knowledge into clinical applications, consolidating its role as a strategic player within the biomedical and pharmaceutical ecosystem. All activities are carried out in accordance with the highest quality and regulatory standards: ISO 9001:2015, GLP, and GMP.
RDI Activity and Technology Transfer
Throughout 2024, CREATIO maintained intense activity in the field of research, development, and innovation (RDI).
The center participated in a total of 13 competitive projects, 11 of which were national and 2 international, thus strengthening its presence in highly demanding scientific calls.
In parallel, 24 new on-demand RDI contracts were signed, involving a combination of public organizations (5) and private companies (19), reinforcing collaboration with industry. Additionally, 17 clinical production services were carried out, demonstrating the operational capacity of the center and enabling the translation of research projects into clinical practice.
In economic terms, CREATIO’s total income reached €1,795,288. This figure reflects a balanced distribution between €741,989 from public and private competitive funding and €1,053,300 from on-demand RDI services, highlighting the center’s financial stability and diversification of income sources.
Education and Talent Development
In 2024, CREATIO continued to commit in the training of scientific talent, with five PhD students in training, two defended doctoral theses, and active participation in specialized forums, including eight scientific events and six in the biopharmaceutical sector.
Acknowledgements
We would like to sincerely thank all the individuals and organizations that have collaborated with CREATIO throughout 2024. Thanks to your support, CREATIO continues to move forward in its mission to transform biomedical research into real solutions for the healthcare system and society..
Staff Profile
Staff
Work Areas
The research team at Creatio, led by Dr. Josep M. Canals, is focused on the research and translation of Advanced Therapies with an emphasis on neurodevelopment and neurological disorders, operating under the ISO 9001:2015 standard. To learn more, click here.
AvantDrug specializes in the validation of new technologies and healthcare products under development by providing expert guidance and conducting regulatory studies in compliance with ISO 9001:2015 and GLP, when required. To learn more, click here.
Creatio develops, validates, and manufactures Advanced Therapy Medicinal Products for clinical research under high-quality standards, including ISO 9001:2015 and GMP. To learn more, click here.
Euros
Totals
Totals
Totals